Efficacy of early intravenous landiolol, an ultrashort-acting beta-blocker on infarct size and its safety in patients with myocardial infarction undergoing primary PCI: a randomized, controlled study

28 August 2020 (08:00 - 18:00)
Organised by:
Congress Presentation Part of: Acute Coronary Syndromes ePosters Reperfusion and Reperfusion Injury ESC Premium Access ESC Congress 2020